ALS (amyotrophic lateral sclerosis) and frequency therapy

Definition:

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord. It leads to muscle weakness, paralysis and eventually the loss of the ability to control voluntary movements.

Causes:

The exact cause of ALS is unknown, but genetic and environmental factors are thought to play a role. About 5-10% of cases are familial, which is due to genetic mutations.

Symptoms:

Muscle weakness and wasting, often starting in the arms or legs.
Difficulty speaking, swallowing and breathing.
Muscle cramps and stiffness.
Progressive paralysis of the muscles.

Diagnosis:

The diagnosis of ALS is based on a thorough clinical examination, medical history and the exclusion of other diseases. Tests may include electromyography (EMG), magnetic resonance imaging (MRI) and blood tests.

treatment:

There is currently no cure for ALS, but treatments can help alleviate symptoms and improve quality of life.

These include:

Medication such as Riluzole, which can slow the progression of the disease.
Physiotherapy and occupational therapy to support mobility and function.
Speech therapy to manage speech and swallowing problems.
Respiratory aids for progressive breathing difficulties.

Progression:

ALS usually progresses rapidly and leads to death within 3 to 5 years of diagnosis, usually due to respiratory failure. However, the course can vary and some patients live significantly longer.

Worth knowing:

ALS is also known as Lou Gehrig's disease, named after the famous baseball player who suffered from the disease.
The disease affects people worldwide and can occur at any age, but is most common in people between the ages of 40 and 70.

research:

Research into ALS is focussed on understanding the mechanisms of the disease, developing new treatments and identifying genetic risk factors. Clinical trials are investigating potential treatments that could slow or stop the progression of the disease.